Bionano Genomics, Inc.

of this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchang

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued January 12, 2026, reporting preliminary financial results for